Kwaliteitsstandaard atypische parkinsonismen

Pagina 243 145. Iranzo, A., J. Santamaria, and E. Tolosa, Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet, 2000. 356 (9238): p. 1329-30. 146. Iranzo, A., et al., Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology, 2004. 63 (5): p. 930-2. 147. Ghorayeb, I., et al., Continuous positive airway pressure for sleep-related breathing disorders in multiple system atrophy: long-term acceptance. Sleep Med, 2005. 6 (4): p. 359-62. 148. Ghaffari, B.D. and B. Kluger, Mechanisms for alternative treatments in Parkinson's disease: acupuncture, tai chi, and other treatments. Curr Neurol Neurosci Rep, 2014. 14 (6): p. 451. 149. Zampieri, M. and E.A. de Souza, Locus of control, depression, and quality of life in Parkinson's Disease. J Health Psychol, 2011. 16 (6): p. 980-7. 150. Gruber-Baldini AL, Y.J., Anderson KE, Shulman LM., Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson's disease. Parkinsonism Relat Disord, 2009. 15 ((9)): p. 665–9. 151. Santos-Garcia, D. and R. de la Fuente-Fernandez, Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease. J Neurol Sci, 2013. 332 (1-2): p. 136-40. 152. Schrag, A., et al., Measuring health-related quality of life in MSA: the MSA-QoL. Mov Disord, 2007. 22 (16): p. 2332-8. 153. O'Sullivan, S.S., et al., Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain, 2008. 131 (Pt 5): p. 1362-72. 154. Krim, E., et al., Multiple system atrophy: prognostic factors in the "MSA-Aquitaine" cohort. Rev Neurol (Paris), 2007. 163 (1): p. 54-65. 155. Kollensperger, M., et al., Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord, 2010. 25 (15): p. 2604-12. 156. Tada, M., et al., Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy. Arch Neurol, 2007. 64 (2): p. 256-60. 157. Schrag, A., et al., Health-related quality of life in multiple system atrophy. Mov Disord, 2006. 21 (6): p. 809-15. 158. Benrud-Larson, L.M., et al., Depressive symptoms and life satisfaction in patients with multiple system atrophy. Mov Disord, 2005. 20 (8): p. 951-7. 159. Hudson, P.L., C. Toye, and L.J. Kristjanson, Would people with Parkinson's disease benefit from palliative care? Palliat Med, 2006. 20 (2): p. 87-94. 160. Miller, N., et al., How do I sound to me? Perceived changes in communication in Parkinson's disease. Clin Rehabil, 2008. 22 (1): p. 14-22. 161. Hendriks, S. Generieke zorgthema Huisartsgeneeskundige zorg . 2014; Available from: http://www.zorgstandaarden.net/nl/wat-is-een-zeldzame-aandoening/generieke-zorgthemas . 162. Roos R, E.D., Tamsma J. , Regievoerend arts biedt houvast. . Med Contact 2013: p. 1510-13. 163. Patientenorgansiaties., V.V.S.O.e., Visiedocument Concentratie en organisatie van zorg bij zeldzame aandoeningen. 2015a. 164. KNMG , Handreiking Verantwoordelijkheidsverdeling bij samenwerking in de zorg . 2010, KNMG. 165. Staveren van, R., Gezamenlijke besluitvorming in de praktijk. Patiëntgerichte gespreksvaardigheden. . Ned Tijdschr Geneeskd., 2011(A3777): p. 155. 166. Vermeulen, M.v.G., WA., Uitzonderlijk lange overleving. NTVG, 2009. 167. ziekten, C.Z.v.c., Raamwerk Individueel Zorgplan. 2012. 168. Heijmans, M., Jansen, D., Rijken, M. , Het gebruik van individuele zorgplannen in de zorg voor mensen met een chronische ziekte. NIVEL, 2015: p. p. 42.